NeoGenomics, Inc. (NEO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SERVICES-TESTING LABORATORIES

12701 COMMONWEALTH DRIVE FORT MYERS, FL 33913

NeoGenomics operates a network of cancer-focused testing laboratories that provides genetic and molecular testing services, including: Cytogenetics testing, which studies normal and abnormal chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization testing, which detects and locates the presence or absence of certain deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which measures the characteristics of cell populations; immunohistochemistry testing, which identifies cell proteins in a tissue section; and molecular testing, which analyzes the DNA and ribonucleic, and the structure and function of genes at a molecular level.

Data based on most recent fiscal year report
Market Cap3.381 Billion Shares Outstanding104.41 Million Avg Volume1.254 Million
1-Yr BETA vs S&P TR0 Current Ratio1.7 Quick Ratio1.56
View SEC Filings from NEO instead.

View recent insider trading info

Funds Holding NEO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NEO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

8 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

108 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CROWTHER BRUCE K

  • Director
35,176 2019-12-31 1

JONES STEVEN C

  • Director
2,063,767 2019-12-30 8

MCKENZIE KATHRYN B CHIEF ACCOUNTING OFFICER

  • Officer
2,273 2019-12-10 2

VAN OORT DOUGLAS M CHAIRMAN AND CEO

  • Officer
  • Director
2,293,481 2019-11-19 5

BALLIET JENNIFER VP AND CHIEF CULTURE OFFICER

  • Officer
22,862 2019-11-15 3

CARDOZA GEORGE PRESIDENT, PHARMA SERVICES

  • Officer
325,831 2019-11-12 5

JOHNSON KEVIN C

  • Director
52,968 2019-10-31 3

SHOVLIN ROBERT J. PRESIDENT, CLINICAL SERVICES

  • Officer
145,640 2019-10-31 5

MURPHY KIERAN PIUS SENIOR VICE PRESIDENT

  • Officer
94,205 2019-09-11 0

HANNAH ALISON L.

  • Director
76,098 2019-09-09 2

BONELLO WILLIAM CHIEF STRATEGY OFFICER

  • Officer
6,735 2019-08-28 4

HIPP RAYMOND R

  • Director
134,102 2019-08-23 4

TETRAULT LYNN A.

  • Director
41,653 2019-06-06 1

KANOVSKY STEPHEN M

  • Director
3,419 2019-06-06 1

VIRAG SHARON CHIEF FINANCIAL OFFICER

  • Officer
10,944 2019-03-01 1

WEISS LAWRENCE MARTIN CHIEF SCIENTIFIC OFFICER

  • Officer
5,893 2019-03-01 1

GENERAL ELECTRIC CO

GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-12-14 0

BRODIE STEVEN G. VP - PHARMA OPERATIONS

  • Officer
45,953 2018-10-22 0

ROSS STEVEN A CIO

  • Officer
9,000 2018-05-10 0

BYWATER STEPHANIE K CHIEF COMPLIANCE OFFICER

  • Officer
528 2018-05-01 0

DENT MICHAEL T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
0 2018-02-15 0

ROBISON WILLIAM J

  • Director
359,474 2017-05-25 0

ALBITAR MAHER CHIEF MEDICAL OFFICER

  • Officer
60,692 2017-04-28 0

MACHULCZ MARK ALAN VICE PRESIDENT OF OPERATIONS

  • Officer
0 2016-01-28 0

HOREL ROBERT H. VICE PRESIDENT GM PATHLOGIC

  • Officer
51,218 2015-12-29 0

JONES STEVEN C EXECUTIVE VP OF FINANCE

ASPEN SELECT HEALTHCARE LP

  • Officer
  • 10% Owner
3,886,629 2015-11-25 0

SMITS MARK W SVP-COMMERCIAL OPERATIONS

  • Officer
9,608 2015-06-01 0

GASPARINI ROBERT P CHIEF SCIENCE OFFICER

  • Officer
8,439 2014-05-22 0

KINDERHOOK, LP

KINDERHOOK GP LLC

KINDERHOOK PARTNERS, LLC

SHAH TUSHAR

CLEARMAN STEPHEN J

  • 10% Owner
5,459,517 2014-01-09 0

DVONCH JEROME J PRINICPAL ACCOUNTING OFFICER

  • Officer
0 2011-05-02 0

MILLER MARYDAWN VICE PRESIDENT OF IT

  • Officer
0 2011-05-02 0

PETERSON PETER M

  • Director
  • 10% Owner
8,191,550 2011-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

JONES STEVEN C - Director by aspen select opportunity fund

2019-12-30 J 100,000 a 100,000 2,063,767.00 indirect

JONES STEVEN C - Director by aspen select opportunity fund

2019-12-30 J 225,000 a 225,000 2,063,767.00 indirect

JONES STEVEN C - Director

2019-12-30 J 100,000 d 0 2,063,767.00 direct

JONES STEVEN C - Director

2019-12-30 J 225,000 d 0 2,063,767.00 direct

JONES STEVEN C - Director by aspen select opportunity fund

2019-12-30 M 100,000 d 125,000 2,063,767.00 indirect

JONES STEVEN C - Director by aspen select opportunity fund

2019-12-30 M 100,000 $4.78 a 1,625,000 2,063,767.00 indirect

MCKENZIE KATHRYN B - Officer CHIEF ACCOUNTING OFFICER

2019-12-10 M 8,000 $8.03 a 10,273 2,273.00 direct

MCKENZIE KATHRYN B - Officer CHIEF ACCOUNTING OFFICER

2019-12-10 M 8,000 d 40,000 2,273.00 direct

MCKENZIE KATHRYN B - Officer CHIEF ACCOUNTING OFFICER

2019-12-10 S 8,000 $26.37 d 2,273 2,273.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments